Listing 1 - 10 of 18 | << page >> |
Sort by
|
Choose an application
Binding proteins --- Biological transport --- Biologisch transport --- Carrier proteins --- Cellules eucaryotiques --- Dragers [Proteïnen] --- Eukaryotic cells --- Eukaryotische cellen --- Membrane transport --- Passive transport [Biological ] --- Physiological transport --- Porteurs protéiques --- Proteïnendragers --- Transport [Biological ] --- Transport [Biologisch ] --- Transport biologique --- Transport proteins --- Biological transport, Active --- Eukaryotic Cells -- metabolism. --- Membrane Proteins --- metabolism --- Biological transport, Active. --- metabolism. --- Eukaryotic Cells -- metabolism --- Metabolism.
Choose an application
This two-volume work covers the molecular and cell biology, genetics and evolution of influenza viruses, the pathogenesis of infection, resultant host innate and adaptive immune response, prevention of infection through vaccination and approaches to the therapeutic control of infection.. Experts at the forefront of these areas provide critical assessments with regard to influenza virology, immunology, cell and molecular biology, and pathogenesis. Volume I provides overviews of the latest findings on molecular determinants of viral pathogenicity, virus entry and cell tropism, pandemic risk assessment, transmission and pathogenesis in animal species, viral evolution, ecology and antigenic variation, while Volume II focuses on the role of innate and adaptive immunity in pathogenesis, development of vaccines and antivirals. .
Influenza. --- Flu --- Flu, Respiratory --- Grippe --- Respiratory flu --- Respiratory infections --- Virus diseases --- Medical virology. --- Immunology. --- Emerging infectious diseases. --- Medicine. --- Virology. --- Infectious Diseases. --- Health Promotion and Disease Prevention. --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Emerging infections --- New infectious diseases --- Re-emerging infectious diseases --- Reemerging infectious diseases --- Communicable diseases --- Immunobiology --- Serology --- Medical microbiology --- Virology --- Health Workforce --- Infectious diseases. --- Health promotion. --- Health promotion programs --- Health promotion services --- Promotion of health --- Wellness programs --- Preventive health services --- Health education --- Microbiology
Choose an application
This two-volume work covers the molecular and cell biology, genetics and evolution of influenza viruses, the pathogenesis of infection, resultant host innate and adaptive immune response, prevention of infection through vaccination and approaches to the therapeutic control of infection.. Experts at the forefront of these areas provide critical assessments with regard to influenza virology, immunology, cell and molecular biology, and pathogenesis. Volume I provides overviews of the latest findings on molecular determinants of viral pathogenicity, virus entry and cell tropism, pandemic risk assessment, transmission and pathogenesis in animal species, viral evolution, ecology and antigenic variation, while Volume II focuses on the role of innate and adaptive immunity in pathogenesis, development of vaccines and antivirals. .
Biomedicine. --- Immunology. --- Vaccine. --- Infectious Diseases. --- Health Promotion and Disease Prevention. --- Medicine. --- Vaccines. --- Emerging infectious diseases. --- Médecine --- Immunologie --- Vaccins --- Maladies infectieuses émergentes --- Biology --- Health & Biological Sciences --- Microbiology & Immunology --- Influenza. --- Flu --- Flu, Respiratory --- Grippe --- Respiratory flu --- Health promotion. --- Infectious diseases. --- Health promotion programs --- Health promotion services --- Promotion of health --- Wellness programs --- Preventive health services --- Health education --- Biologicals --- Immunobiology --- Life sciences --- Serology --- Clinical sciences --- Medical profession --- Human biology --- Medical sciences --- Pathology --- Physicians --- Respiratory infections --- Virus diseases --- Emerging infections --- New infectious diseases --- Re-emerging infectious diseases --- Reemerging infectious diseases --- Communicable diseases --- Health Workforce
Choose an application
Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans resulting in numerous fatalities. The rapid expansion in their geographic distribution and the possibility that these viruses could acquire the ability to spread from person to person raise the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have limited antigenic relationships to the highly pathogenic H5N1 strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop effective vaccines for pandemic influenza viruses, and to overcome the limitations inherent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine production; which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations include the requirement that the current inactivated influenza vaccines be administered using needles and syringes, requiring trained personnel, which could be a bottleneck when attempting to vaccinate large populations in mass campaigns. In addition, the current inactivated vaccines which are delivered by injection elicit limited protective immunity in the upper respiratory tract where the infection process is initiated. Most of these limitations of the current vaccines are being addressed by research on novel approaches to vaccine development and delivery that are described in many of the chapters in this volume.
Disease Outbreaks. --- Influenza vaccines. --- Influenza Vaccines -- therapeutic use. --- Influenza, Human. --- Influenzavirus A. --- Influenza Vaccines --- Influenzavirus A --- Influenza, Human --- Disease Outbreaks --- Orthomyxoviridae --- Viral Vaccines --- Public Health --- Orthomyxoviridae Infections --- Respiratory Tract Infections --- Environment and Public Health --- RNA Viruses --- Vaccines --- Respiratory Tract Diseases --- RNA Virus Infections --- Diseases --- Biological Products --- Virus Diseases --- Viruses --- Health Care --- Vertebrate Viruses --- Complex Mixtures --- Organisms --- Chemicals and Drugs --- Microbiology & Immunology --- Biology --- Health & Biological Sciences --- Viral vaccines. --- Virus vaccines --- Influenza virus vaccines --- Medicine. --- Immunology. --- Pharmacology. --- Virology. --- Public health. --- Biomedicine. --- Pharmacology/Toxicology. --- Public Health. --- Community health --- Health services --- Hygiene, Public --- Hygiene, Social --- Public health services --- Public hygiene --- Sanitary affairs --- Social hygiene --- Health --- Human services --- Biosecurity --- Health literacy --- Medicine, Preventive --- National health services --- Sanitation --- Microbiology --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemicals --- Chemotherapy --- Drugs --- Pharmacy --- Immunobiology --- Life sciences --- Serology --- Clinical sciences --- Medical profession --- Human biology --- Pathology --- Physicians --- Physiological effect --- Viral vaccines --- Medical virology. --- Toxicology. --- Medicine --- Pharmacology --- Poisoning --- Poisons --- Medical microbiology --- Virology --- Virus diseases --- Toxicology
Choose an application
Vaccines --- Design. --- Biologicals --- Vacunes --- Immunoteràpia --- Nanopartícules --- Nanomedicina --- Medicina --- Nanotecnologia --- Materials nanoestructurats --- Partícules (Matèria) --- Nanocristalls --- Terapèutica immunològica --- Immunologia clínica --- Terapèutica --- Adjuvants immunològics --- Seroteràpia --- Timosina --- Vacunació --- Vacunes antibacterianes --- Vacuna de la malària --- Vacunes antivíriques --- Immunitat
Choose an application
Immunology. Immunopathology --- Hygiene. Public health. Protection --- Pharmacology. Therapy --- Medical microbiology, virology, parasitology --- immunologie --- volksgezondheid --- farmacie --- farmacologie --- pandemie --- virologie --- toxicologie --- influenza --- vaccinatie
Choose an application
This two-volume work covers the molecular and cell biology, genetics and evolution of influenza viruses, the pathogenesis of infection, resultant host innate and adaptive immune response, prevention of infection through vaccination and approaches to the therapeutic control of infection.. Experts at the forefront of these areas provide critical assessments with regard to influenza virology, immunology, cell and molecular biology, and pathogenesis. Volume I provides overviews of the latest findings on molecular determinants of viral pathogenicity, virus entry and cell tropism, pandemic risk assessment, transmission and pathogenesis in animal species, viral evolution, ecology and antigenic variation, while Volume II focuses on the role of innate and adaptive immunity in pathogenesis, development of vaccines and antivirals. .
Immunology. Immunopathology --- Hygiene. Public health. Protection --- Medical microbiology, virology, parasitology --- Pathological biochemistry --- Infectious diseases. Communicable diseases --- Human medicine --- immunologie --- medische biochemie --- preventieve gezondheidszorg --- medische virologie --- pandemie --- biochemie --- biomedische wetenschappen --- virologie --- gezondheidspromotie --- besmettelijke ziekten --- influenza --- vaccinatie --- moleculaire biologie
Choose an application
This two-volume work covers the molecular and cell biology, genetics and evolution of influenza viruses, the pathogenesis of infection, resultant host innate and adaptive immune response, prevention of infection through vaccination and approaches to the therapeutic control of infection.. Experts at the forefront of these areas provide critical assessments with regard to influenza virology, immunology, cell and molecular biology, and pathogenesis. Volume I provides overviews of the latest findings on molecular determinants of viral pathogenicity, virus entry and cell tropism, pandemic risk assessment, transmission and pathogenesis in animal species, viral evolution, ecology and antigenic variation, while Volume II focuses on the role of innate and adaptive immunity in pathogenesis, development of vaccines and antivirals. .
Choose an application
This book introduces nanoparticles as a powerful platform for vaccine design. Current challenges in vaccine development are discussed and the unique advantages nanoparticles provide in overcoming these challenges are explored. The authors offer fascinating insights into the immunological assets of using nanoparticles as delivery vehicles or adjuvants and present different materials that are being used in nanoparticle-based vaccine development, covering peptides, proteins, polymers, virus-like particles, and liposomes. Its contemporary research insights and practical examples for applications make this volume an inspiring read for researchers and clinicians in vaccinology and immunology. Chapter "Liposome Formulations as Adjuvants for Vaccines" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
Chemical structure --- Chemistry --- History of human medicine --- Human physiology --- Medical microbiology, virology, parasitology --- moleculen --- nanotechniek --- farmacologie --- chemie --- virologie --- fysiologie --- atomen
Choose an application
Double-stranded RNA --- RNA Viruses --- RNA, Double-Stranded --- RNA Viruses
Listing 1 - 10 of 18 | << page >> |
Sort by
|